- ►diabetesjournals.org E Bosi, S Braghi, P Maffi, M Scirpoli, F … - Diabetes, 2001 - Am Diabetes Assoc Islet allotransplantation into patients with autoimmune type 1 diabetes
represents a reexposure to autoantigen. Here, measurement of antibodies to GAD
and IA-2 autoantigens before and after islet transplantation in 36 patients ... Cited by 52 - Related articles - BL Direct - All 8 versions
C Jaeger, MD Brendel, BJ Hering, M Eckhard, … - Diabetes, 1997 - Am Diabetes Assoc Alloimmunity has been uncovered to be a cause of graft loss representing a major
barrier for clinical islet transplantation, and several studies are designed to
evaluate new strategies for immunosuppression to prevent alloimmunity. In ... Cited by 72 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org [PDF] BO Roep, I Stobbe, G Duinkerken, JJ Van … - Diabetes, 1999 - Am Diabetes Assoc Allogeneic islet transplantation can restore an insulin- independent state in
C-peptide–negative type 1 dia- betic patients. We recently reported three
cases of sur- viving islet allografts that were implanted in type 1 ... Cited by 84 - Related articles - BL Direct - All 4 versions
C Jaeger, MD Brendel, M Eckhard, RG Bretzel - Experimental and Clinical Endocrinology and Diabetes, 2000 - thieme-connect.com At present, indications for clinical islet transplantation exist almost
exclusively in type-1 diabetic patients with end-stage renal disease receiving
the islets either simultaneously with or after an already established ... Cited by 19 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org L Luzi, G Perseghin, MD Brendel, I Terruzzi, … - Diabetes, 2001 - Am Diabetes Assoc Successful intraportal islet transplantation normalizes glucose metabolism in
diabetic humans. To date, full function is not routinely achieved after islet
transplantation in humans, with most grafts being characterized by only ... Cited by 51 - Related articles - BL Direct - All 4 versions
F Bertuzzi, F Grohovaz, P Maffi, A Caumo, L … - Diabetologia, 2002 - Springer Refinements in procedures of pancreas enzymatic digestion, and new
immunosuppression strategies have allowed clinical trials of islet
transplantation in patients with Type I (insulin-dependent) diabetes ... Cited by 43 - Related articles - BL Direct - All 3 versions
CH Thivolet, S Abou-Amara, X Martin, N … - Transplantation, 2000 - journals.lww.com Skip Navigation Links Home > January 15, 2000 - Volume 69 - Issue 1 >
Serological Markers of Recurrent Beta Cell Destruction in Di... ... 1 INSERM
449, Faculty of Medicine RTH Laënnec. Cited by 17 - Related articles - BL Direct - All 3 versions
S Braghi, E Bonifacio, A Secchi, V Di Carlo, G … - DIABETES-NEW YORK-, 2000 - Am Diabetes Assoc Pancreas transplantation in patients with type 1 dia- betes presents allogeneic
-cell autoantigens to the immune system long after the initial -cell destruction
that leads to diabetes has occurred. The aims of this study were to ... Cited by 32 - Related articles - BL Direct - All 4 versions
- ►endojournals.org AM Davalli, P Maffi, C Socci, F Sanvito, M … - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc We report a case of long-term (>4 yr) successful intrahepatic islet
transplantation into a type 1 diabetic patient chronically immunosuppressed for
a prior kidney graft. The exogenous insulin requirement decreased ... Cited by 33 - Related articles - BL Direct - All 5 versions
